Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:accreditation |
gptkb:CLIA
CAP |
| gptkbp:acquisition |
Covance
|
| gptkbp:CEO |
gptkb:Adam_H._Schechter
|
| gptkbp:employees |
over 60,000
|
| gptkbp:focus |
Drug development
|
| gptkbp:founded |
1978
|
| gptkbp:has_a_focus_on |
Cell therapy
Gene therapy Medical devices Oncology Regenerative medicine Neurology Infectious diseases Precision medicine Vaccines Metabolic disorders Biologics Cardiovascular Global health initiatives Data analytics in healthcare Rare diseases Biosimilars Diversity in clinical trials Sustainability in healthcare Patient engagement strategies Real-world evidence Therapeutic areas Companion diagnostics Artificial intelligence in drug development Machine learning in clinical trials Patient-centric trials Digital_health_solutions Digital_biomarkers |
| gptkbp:has_partnerships_with |
Academic institutions
Government agencies Biotech_companies |
| gptkbp:headquarters |
gptkb:Burlington,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
Labcorp Drug Development
|
| gptkbp:industry |
Healthcare
|
| gptkbp:offers |
Statistical analysis
Data management Patient recruitment Regulatory consulting Clinical trial management Biomarker_testing |
| gptkbp:operates_in |
Global
|
| gptkbp:parentCompany |
gptkb:Labcorp
|
| gptkbp:partnerships |
Pharmaceutical companies
|
| gptkbp:services |
Clinical trials
Laboratory testing |
| gptkbp:subsidiary |
gptkb:Covance_Drug_Development
Labcorp_Clinical_Trials |
| gptkbp:type |
Clinical laboratory
|
| gptkbp:website |
www.labcorp.com
|